Phoenix® WinNonlin® – The Industry Standard for NCA and PK/PD Modeling and Simulation
Phoenix WinNonlin is the industry standard for non-compartmental analysis (NCA), pharmacokinetic/pharmacodynamic (PK/PD) and toxicokinetic (TK) modeling. Integrated tools for data processing, post-analysis processing, table creation and graphics create an all-in-one collaboration workbench used by scientists, reviewers, medical writers, and quality assurance staff for drug development projects.
Trusted by Scientists and Regulators around the Globe
With a proven 30-year global history, Phoenix WinNonlin is used by over 6,000 scientists at 1,500 organizations in 60 countries, including the top pharmaceutical companies, and 200 academic institutes. Regulatory agencies, including seven divisions of the US Food and Drug Administration (FDA), Japan Pharmaceutical and Medical Device Agency (PMDA), China Food and Drug Administration (CFDA), and the UK Medicines and Healthcare Products Regulatory Agency (MHRA), use Phoenix WinNonlin to evaluate drug submissions.
An Intuitive Graphical User Interface Delivers the Most Efficient PK/PD Analysis Available Today.
The intuitive graphical user interface (GUI) enables users to spend less time on tedious data preparation, manipulation, analysis, and reporting allowing more to model, interpret, and understand the data. The result? Efficient drug development decisions can be made faster with more confidence.
The Most Comprehensive Set of Analysis Tools for any Non-clinical or Clinical PK/PD Study
From early non-clinical research with a few animals to large clinical trials, the NCA engine, individual PK/PD modeling engine, and statistical analysis tools can be used for a wide-range of studies and analyses
Statistical Tools that Help Answer Critical Questions:
Did the new formulation meet bioequivalence criteria? Is the exposure dose proportional? Did the drug cause an increase in a biomarker? Use statistical tools in WinNonlin to integrate and report inferential analysis of study results.
Powerful Integrated Graphics Engine and Table Generator
The integrated graphics engine in Phoenix WinNonlin automatically creates publication-quality plots and figures and well-organized tables to help create standardized PK/PD reports more efficiently. The output can be quickly and easily attached to a PK/PD report for communicating results internally and to regulatory agencies.
Data Processing and Preparation Tools:
Analysis dataset preparation is a breeze with Phoenix WinNonlin’s data processing tools. The Phoenix workflow traces data from the moment it is imported through the final analysis, preventing data loss and costly re-analysis.
Supports and Simplifies Compliance Efforts :
The Validation Suite for WinNonlin uses automated technology to complete validation in days not months. And full integration of Phoenix WinNonlin with the Phoenix Knowledgebase Server (PKS) enables the management of clinical and non-clinical PK and PD data and analyses in compliance with the US FDA electronic records and signatures regulation (21 CFR Part 11).
We’re committed to your success :
We provide a wide range of education and support tools to get you started and our informative blog and instructive webinars keep you up-to-date with the most important advancements in modelling. To learn why Phoenix WinNonlin is the trusted, proven industry standard software tool for PK/PD modeling, non-compartmental and compartmental analysis. Educational
Disclaimer : The information on this Certara product line including names of other Software products/companies and brands, customers, customer statements and application labels are information taken from the original developer's website. 4am Software makes no additional claims to the information contained. Furthermore 4am Software Pty Ltd., does not make any claims of performance of the products, links with other related products or industry standards limited to PK/PD analysis or beyond. The sole purpose of information is to provide customers complete details in making a decision to purchase the products.